APA (7th ed.) Citation

Artzenroth, J. C., Tintelnot, J., Haag, G. M., Gökkurt, E., Steffens, J., & Stein, A. (2023). Combining poly-(ARD-ribose) polymerase and programmed cell death protein 1 inhibition in a patient with esophagogastric adenocarcinoma. S. Karger AG, Medical and Scientific Publishers. https://doi.org/10.11588/heidok.00035301

Chicago Style (17th ed.) Citation

Artzenroth, Jule Cecilia, Joseph Tintelnot, Georg Martin Haag, Eray Gökkurt, Johann Steffens, and Alexander Stein. Combining Poly-(ARD-ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma. Basel, Switzerland: S. Karger AG, Medical and Scientific Publishers, 2023. https://doi.org/10.11588/heidok.00035301.

MLA (9th ed.) Citation

Artzenroth, Jule Cecilia, et al. Combining Poly-(ARD-ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma. S. Karger AG, Medical and Scientific Publishers, 2023. https://doi.org/10.11588/heidok.00035301.